Repligen corporation RGEN.US 總覽分析
RGEN 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
價值面評分優異,但股利評分未超過2分,若公司開始配息,可能會有更優異的投資結果
RGEN 近期報酬表現
0.76%
Repligen corporation
1.31%
同產業平均
0.58%
S&P500
與 RGEN 同產業的標的表現
- DHR Danaher corp價值 5 分趨勢 2 分波段 4 分籌碼 4 分股利 3 分查看更多
RGEN 公司資訊
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.